Breaking News Instant updates and real-time market news.

MCD

McDonald's

$189.15

-4.78 (-2.46%)

, VZ

Verizon

$60.33

-0.02 (-0.03%)

10:20
11/04/19
11/04
10:20
11/04/19
10:20

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. McDonald's (MCD) downgraded to Neutral from Overweight at Piper Jaffray with analyst Nicole Miller Regan saying while the company's fundamentals are solid, CEO changes "of this magnitude tend to be disruptive." 2. Verizon (VZ) downgraded to Neutral from Buy at Nomura Instinet with analyst Jeffrey Kvaal saying AT&T's (T) new price reductions, and T-Mobile's (TMUS) likely response, reduces visibility into Verizon's near-term growth trajectory. 3. Delphi Technologies (DLPH) downgraded to Equal Weight from Overweight at Barclays with analyst Brian Johnson saying the company's Q3 results, while not terrible," introduced a "handful of warning signals" that give pause when thinking through the company's transition path over the next two years. 4. Papa John's (PZZA) downgraded to Hold from Buy at Jefferies with analyst Alexander Slagle saying the company is on the path to recovery, but the stock now reflects this trajectory as well as the potential for its same-store-sales to turn modestly positive in Q4 and 2020. 5. Harley-Davidson (HOG) downgraded to Underweight from Sector Weight at KeyBanc with analyst Brett Andress citing dealer checks, deteriorating new and used conditions and a lack of near-term catalysts for the downgrade. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

MCD

McDonald's

$189.15

-4.78 (-2.46%)

VZ

Verizon

$60.33

-0.02 (-0.03%)

DLPH

Delphi Technologies

$13.52

0.75 (5.87%)

PZZA

Papa John's

$55.94

-2.03 (-3.50%)

HOG

Harley-Davidson

$38.80

-0.55 (-1.40%)

  • 06

    Nov

  • 13

    Nov

  • 19

    Nov

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 11

    Dec

  • 30

    Jan

MCD McDonald's
$189.15

-4.78 (-2.46%)

11/04/19
LEHM
11/04/19
NO CHANGE
Target $225
LEHM
Overweight
McDonald's should be bought on weakness from CEO change, says Barclays
While the CEO transition announced by McDonald's was unexpected, "and therefore not a good thing," the change was not due to operational or financial issues, but rather personal conduct, Barclays analyst Jeffrey Bernstein tells investors in a research note. The analyst is confident the company has the depth in leadership to maintain momentum as the global quick service restaurant leader. As such, he's a buyer of McDonald's shares on any weakness and keeps an Overweight rating on the name with a $225 price target.
11/04/19
FBCO
11/04/19
NO CHANGE
Target $230
FBCO
Outperform
Credit Suisse views any pullback in McDonald's stock as buying opportunity
Credit Suisse analyst Lauren Silberman tells investors in a research note that she thinks McDonald's shares could be under "modest" pressure Monday after the company announced that Steve Easterbrook has separated from the company following the board's determination that he violated company policy and demonstrated poor judgment involving a recent consensual relationship with an employee. Easterbrook was "highly regarded" in the investment community and among franchisees, and potential concerns of franchisee sentiment regarding new leadership, Silberman says, but adds that McDonald's has a "talented" bench and expects management and the board have a like-minded strategy. She says the management transition does not alter her positive view of the company, and views any material pullback pullback in the stock around the CEO change as a buying opportunity. Silberman maintains an Outperform rating and $230 price target.
11/04/19
SPHN
11/04/19
NO CHANGE
Target $225
SPHN
Overweight
McDonald's shares attractive on the pullback, says Stephens
The departure of CEO Steve Easterbrook is a "fairly significant negative" for investors, given his history of impressive and consistent global results, Stephens analyst Will Slabaugh tells investors in a research note. The analyst, however, likes the "quick choice" of Chris Kempczinski as the next CEO, given his existing relationships with domestic operators and "leadership experience during some of the U.S.'s best years in decades." Slabaugh likes McDonald's here and views the shares as attractive on the recent pullback. He keeps an Overweight rating on the name with a $225 price target. McDonald's in premarket trading is down 3%, or $5.09, to $188.85.
11/04/19
MKMP
11/04/19
NO CHANGE
Target $225
MKMP
Buy
McDonald's price target lowered to $225 from $240 at MKM Partners
MKM Partners analyst Brett Levy lowered his price target on McDonald's to $225 after its abrupt announcement of a CEO change over the weekend. The analyst notes while the developments surrounding the transition may not impact results, the company may suffer from a "psychological impact" and the stock could see some near-term pressure. Levy adds that McDonald's has been under pressure for a couple of months now, and the transition will not "ease any recent concerns".
VZ Verizon
$60.33

-0.02 (-0.03%)

11/04/19
NOMU
11/04/19
DOWNGRADE
Target $65
NOMU
Neutral
Nomura Instinet downgrades Verizon to Neutral after AT&T price cuts
Nomura Instinet analyst Jeffrey Kvaal downgraded Verizon Communications (VZ) to Neutral from Buy with a price target of $65, down from $67. The stock closed Friday down 11c to $60.37. AT&T's (T) new price reductions, and T-Mobile's (TMUS) likely response, reduces visibility into Verizon's near-term growth trajectory, Kvaal tells investors in a research note. The analyst now has lower confidence into Verizon's long-term ability to lift pricing for 5G. While he prefers wireless over fixed over time, he moves to a Neutral stance on Verizon.
11/04/19
NOMU
11/04/19
DOWNGRADE
Target $65
NOMU
Neutral
Verizon downgraded to Neutral from Buy at Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal downgraded Verizon Communications to Neutral from Buy with a $65 price target.
10/28/19
GUGG
10/28/19
NO CHANGE
Target $69
GUGG
Buy
Verizon price target raised to $69 from $65 at Guggenheim
Guggenheim analyst Mike McCormack raised his price target for Verizon Communications to $69 from $65 saying the company reported "strong" Q3 Wireless results, with revenue, earnings, and free cash flow coming in ahead of consensus. The analyst maintains a Buy rating on the shares.
10/28/19
ADAM
10/28/19
NO CHANGE
Target $8.5
ADAM
Buy
Inseego price target raised to $8.50 from $7.00 at Canaccord
Canaccord analyst T. Michael Walkley raised his price target on Inseego (INSG) to $8.50 from $7.00. Management decided to increase near-term investments to support additional products for a growing global 5G opportunity. The company launched the industry's first 5G mobile hotspot and Walkley believes volumes will ramp through year-end as Verizon (VZ) launches an increasing number of cities.Walkley reiterated his Buy rating on Inseego shares.
DLPH Delphi Technologies
$13.52

0.75 (5.87%)

11/04/19
LEHM
11/04/19
DOWNGRADE
Target $13
LEHM
Equal Weight
Delphi Technologies downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Brian Johnson downgraded Delphi Technologies to Equal Weight from Overweight with a $13 price target.
11/04/19
LEHM
11/04/19
DOWNGRADE
Target $13
LEHM
Equal Weight
Barclays downgrades Delphi Technologies, cuts target to $13 from $23
Barclays analyst Brian Johnson downgraded Delphi Technologies to Equal Weight from Overweight with a price target of $13, down from $23. The company's Q3 results, while not terrible," introduced a "handful of warning signals" that give pause when thinking through the company's transition path over the next two years, Johnson tells investors in a research note. Delphi lowered Q4 guidance, unveiled a multi-year restructuring plan and indicated that 2020 growth and margins would again come under pressure after an already "transitionary" 2019, says the analyst. As such, he suspects the company's "mid-term portfolio transition may be more painful than the market is bracing for."
11/01/19
OPCO
11/01/19
DOWNGRADE
OPCO
Perform
Delphi Technologies downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Noah Kaye downgraded Delphi Technologies to Perform from Outperform and removed his $20 price target after the company laid out a transformational plan to achieve $150M in operating cost savings by 2022 while lowering FY19 outlook and pointing directionally to lower FY20 sales amid challenging market dynamics. The analyst tells investors in a research note that he sees fewer company-specific catalysts over the next 12-18 months.
10/16/19
GUGG
10/16/19
INITIATION
GUGG
Guggenheim initiates Auto Suppliers with cautious sector view
Guggenheim analyst Ali Faghri initiated coverage last night on the Auto Suppliers with a cautious sector view. The automotive sector is facing increasing cyclical pressures globally, says Faghri, who forecasts flat to negative global industry production volumes through 2021. This creates a challenging operating environment for auto suppliers, the analyst tells investors in a research note. Faghri believes Europe represents the most significant risk to the group's outlook, pointing out that his work suggests "macro headwinds and disruptive emissions regulations will significantly impact vehicle demand in the region over the next few years." The analyst initiated coverage of Aptiv (APTV) and Gentex (GNTX) with Buy ratings. For Aptiv, he sees high single-digit organic growth through 2022 driven by active safety and electric vehicle content gains. For Gentex, the analyst sees upside to 2019 consensus due to stronger gross margins and visibility for continued above market growth. Faghri rounded out his coverage with Neutral ratings on BorgWarner (BWA), Delphi Technologies (DLPH), Lear (LEA), Visteon (VC) and Veoneer (VNE).
PZZA Papa John's
$55.94

-2.03 (-3.50%)

11/04/19
JEFF
11/04/19
DOWNGRADE
Target $58
JEFF
Hold
Papa John's downgraded to Hold from Buy at Jefferies
Jefferies analyst Alexander Slagle downgraded Papa John's International to Hold from Buy with a $58 price target.
10/29/19
BTIG
10/29/19
NO CHANGE
Target $62
BTIG
Buy
Papa John's price target raised to $62 from $54 at BTIG
BTIG analyst Peter Saleh raised his price target on Papa John's to $62 and kept his Buy rating, saying the company's "turnaround" is starting to "take shape" under the leadership of a new CEO and CMO. The analyst believes that Papa John's will focus more on its national ads and menu innovation, adding that it should be able to pick "long-hanging" operational and restaurant margin opportunities. Saleh also raises his Papa John's expected FY20 EPS view by 14c to $1.46.
11/04/19
JEFF
11/04/19
DOWNGRADE
Target $58
JEFF
Hold
Papa John's downgraded to Hold from Buy on valuation at Jefferies
Jefferies analyst Alexander Slagle downgraded Papa John's International to Hold from Buy with an unchanged price target of $58. The company is on the path to recovery, but the stock now reflects this trajectory as well as the potential for its same-store-sales to turn modestly positive in Q4 and 2020, Slagle tells investors in a research note. Further, the analyst believes "material upside" to sales seems unlikely given competitive headwinds in the space. As such, he views Papa John's risk/reward as fair at current share levels.
10/24/19
NRCS
10/24/19
NO CHANGE
Target $70
NRCS
Buy
Papa John's checks show solid U.S. same-store sales improvement, says Northcoast
Northcoast analyst Jim Sanderson reiterates his Buy rating and $70 price target on Papa John's after his recent checks lead him to believe U.S. franchise operators are experiencing "solid" improvements in same-store sales ranging from mid-single-digits to low double-digits percent in Q3. His checks also show expectations for Q4 remain "cautiously optimistic," Sanderson tells investors.
HOG Harley-Davidson
$38.80

-0.55 (-1.40%)

11/04/19
KEYB
11/04/19
DOWNGRADE
Target $33
KEYB
Underweight
Harley-Davidson downgraded to Underweight at KeyBanc
KeyBanc analyst Brett Andress downgraded Harley-Davidson to Underweight from Sector Weight with a $33 price target. In a research note to investors, Andress cites dealer checks, deteriorating new and used conditions and a lack of near-term catalysts for the downgrade. The analyst sees Road Glide, which represents 15%-20% of Harley's U.S. retail units, pressure further weighing on mix and gross profit into FY20, potentially driving an EPS headwind of about 25c.
11/04/19
KEYB
11/04/19
DOWNGRADE
Target $33
KEYB
Underweight
Harley-Davidson downgraded to Underweight from Sector Weight at KeyBanc
KeyBanc analyst Brett Andress downgraded Harley-Davidson to Underweight from Sector Weight with a $33 price target.
10/29/19
MSCO
10/29/19
NO CHANGE
Target $43
MSCO
Overweight
Morgan Stanley comfortable with Harley's upside potential, says 'ride the rally'
Morgan Stanley analyst Adam Jonas raised his estimates for Harley-Davidson to reflect the higher conviction in shipment stabilization and his expectation for increased motorcycle operating margins in FY20. The analyst, who said he is "comfortable with Harley's upside potential," suggests that investors "ride the Harley relief rally into 2020" as he expressed confidence in management to develop a strategy to diversify the business and hit their guidance. Jonas reiterates an Overweight rating on Harley and raised his price target on the shares to $43 from $42.
10/28/19
LEHM
10/28/19
NO CHANGE
Target $32
LEHM
Underweight
Barclays remains cautious on shares of Harley-Davidson
Barclays analyst Felicia Hendrix remains cautious on Harley shares "until the company is at a clear inflection point." The company reported a better than expected quarter, but retail sales "remain choppy" and continue to decline in the U.S., Hendrix tells investors in a research note. Beyond rebuilding a new base of riders, Harley's largest challenges include working through the "substantial" used bike inventory and competing successfully in the new middleweight and small displacement segments next year, says the analyst. Hendrix keeps an Underweight rating on Harley-Davidson shares with a $32 price target.

TODAY'S FREE FLY STORIES

WFT

Weatherford

$0.00

(0.00%)

18:49
12/13/19
12/13
18:49
12/13/19
18:49
Hot Stocks
Weatherford completes financial restructuring, emerges from Chapter 11 »

Weatherford announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$57.71

-0.81 (-1.38%)

18:40
12/13/19
12/13
18:40
12/13/19
18:40
Hot Stocks
Centene CEO: Our big markets are growing, we're gaining share »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LYV

Live Nation

$64.24

-5.205 (-7.50%)

, ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

18:29
12/13/19
12/13
18:29
12/13/19
18:29
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

LYV

Live Nation

$64.24

-5.205 (-7.50%)

ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

STE

Steris

$151.93

-1.745 (-1.14%)

AMG

Affiliated Managers

$85.18

-1.77 (-2.04%)

TRIP

TripAdvisor

$29.24

-0.2 (-0.68%)

MAC

Macerich

$26.04

-0.46 (-1.74%)

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 23

    Mar

PLAN

Anaplan

$51.80

1.44 (2.86%)

18:23
12/13/19
12/13
18:23
12/13/19
18:23
Hot Stocks
Anaplan CEO: Digitization has really started to accelerate »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPX

WPX Energy

$10.92

-0.24 (-2.15%)

18:08
12/13/19
12/13
18:08
12/13/19
18:08
Periodicals
WPX Energy in talks to acquire Felix Energy assets for $2.5B, Bloomberg says »

WPX Energy is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

HLIT

Harmonic

$7.94

-0.25 (-3.05%)

17:47
12/13/19
12/13
17:47
12/13/19
17:47
Hot Stocks
Harmonic CFO sells 28K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$32.84

(0.00%)

17:36
12/13/19
12/13
17:36
12/13/19
17:36
Hot Stocks
Breaking Hot Stocks news story on Horizon Pharma »

Horizon Pharma up 9.6% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:33
12/13/19
12/13
17:33
12/13/19
17:33
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin rises 1.4% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

THMO

ThermoGenesis

$2.88

(0.00%)

17:31
12/13/19
12/13
17:31
12/13/19
17:31
Syndicate
Breaking Syndicate news story on ThermoGenesis »

ThermoGenesis files $30M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:30
12/13/19
12/13
17:30
12/13/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Amarin 

Amarin trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

QTNT

Quotient

$8.60

-0.165 (-1.88%)

17:28
12/13/19
12/13
17:28
12/13/19
17:28
Syndicate
Breaking Syndicate news story on Quotient »

Quotient files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

, GVA

Granite Construction

$26.21

-1.335 (-4.85%)

17:27
12/13/19
12/13
17:27
12/13/19
17:27
Hot Stocks
Breaking Hot Stocks news story on Arrowhead, Granite Construction »

Arrowhead to replace…

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

, SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

17:25
12/13/19
12/13
17:25
12/13/19
17:25
Hot Stocks
Oasis, Southwestern to replace Unit Corp., Frontier in S&P 600 at open on 12/23 »

Oasis Petroleum (OAS) and…

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:24
12/13/19
12/13
17:24
12/13/19
17:24
Hot Stocks
Amarin raises guidance after FDA approves Vascepa »

Amarin (AMRN) shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

, LEA

Lear

$129.43

-0.84 (-0.64%)

17:22
12/13/19
12/13
17:22
12/13/19
17:22
Hot Stocks
Grand Canyon, Lear to replace Oasis, Southwestern in S&P 400 at open on 12/23 »

Grand Canyon Education…

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

RTN

Raytheon

$217.31

-0.93 (-0.43%)

17:20
12/13/19
12/13
17:20
12/13/19
17:20
Hot Stocks
Raytheon awarded $123.53M Navy contract modification »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYV

Live Nation

$64.24

-5.205 (-7.50%)

, ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

17:19
12/13/19
12/13
17:19
12/13/19
17:19
Hot Stocks
Live Nation, Zebra Technologies, Steris to move to S&P 500 at open on 12/23 »

Live Nation (LYV), Zebra…

LYV

Live Nation

$64.24

-5.205 (-7.50%)

ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

STE

Steris

$151.93

-1.745 (-1.14%)

AMG

Affiliated Managers

$85.18

-1.77 (-2.04%)

TRIP

TripAdvisor

$29.24

-0.2 (-0.68%)

MAC

Macerich

$26.04

-0.46 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

BAESY

BAE Systems

$0.00

(0.00%)

17:15
12/13/19
12/13
17:15
12/13/19
17:15
Hot Stocks
BAE Systems awarded $249.15M Army contract modification »

BAE Systems was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WST

West Pharmaceutical

$146.32

-0.14 (-0.10%)

17:02
12/13/19
12/13
17:02
12/13/19
17:02
Hot Stocks
West Pharmaceutical announces 848K share repurchase authorization »

On December 10, 2019, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:02
12/13/19
12/13
17:02
12/13/19
17:02
Earnings
Amarin sees FY20 revenue $650M-$700M, consensus $654.55M »

With respect to 2020,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

IBIO

iBio

$0.22

-0.0179 (-7.43%)

17:01
12/13/19
12/13
17:01
12/13/19
17:01
Hot Stocks
iBio receives NYSE noncompliance notice »

iBio, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLT

Applied Therapeutics

$21.23

0.29 (1.38%)

16:59
12/13/19
12/13
16:59
12/13/19
16:59
Syndicate
Breaking Syndicate news story on Applied Therapeutics »

Applied Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:59
12/13/19
12/13
16:59
12/13/19
16:59
Earnings
Amarin raises FY19 revenue view to $410M-$425M from $380M-$420M 

FY19 consensus $410.25M.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

BIO

Bio-Rad

$354.69

-8.005 (-2.21%)

16:56
12/13/19
12/13
16:56
12/13/19
16:56
Hot Stocks
Bio-Rad progressing from ransomware attack recovery detected on Dec 5th »

Bio-Rad Laboratories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:50
12/13/19
12/13
16:50
12/13/19
16:50
Hot Stocks
Amarin confirms FDA approval of Vascepa »

Amarin announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.